To conclude, these findings in the present investigation shed light on the carcinogenic action of LINC00242 in GC through its interaction with miR-141 and FOXC1, providing a novel therapeutic candidate to develop treatment modalities against GC. The gene discussed is FOXC1; the disease is gastric cancer.